on POXEL (EPA:POXEL)
Poxel Releases Half-Year Financial Report for 2024
Poxel SA, a clinical stage biopharmaceutical company listed on Euronext, has announced the release of its 2024 half-year financial report. Available from December 23, 2024, this report details the company’s finances up to June 30, 2024. It comprises condensed consolidated financial statements and a half-year activity report. A certification from the responsible party of the document is included.
The report features the Statutory Auditors’ limited review. However, due to uncertainties regarding the company's going concern, the auditors were unable to reach a definitive conclusion. Interested parties can access the document on Poxel’s website, available in French.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all POXEL news